
Treatment with the targeted drug gilteritinib (Xospata) can improve survival compared with chemotherapy for some people with acute myeloid leukemia (AML), new results from a large clinical trial show. All participants enrolled in the trial had […]
Treatment with the targeted drug gilteritinib (Xospata) can improve survival compared with chemotherapy for some people with acute myeloid leukemia (AML), new results from a large clinical trial show. All participants enrolled in the trial had […]
In children with acute lymphoblastic leukemia (ALL), radiation therapy to prevent the cancer from returning in the brain is likely unnecessary, according to a new study. Radiation can even be omitted for children at […]
In what could be a major breakthrough, scientists at the Korea Advanced Institute of Science and Technology (KAIST) in South Korea claim to have identified the cellular origin of glioblastoma, a fast-growing type […]
A targeted cancer drug already in use to treat some women with ovarian and breast cancer may also be beneficial for some people with advanced pancreatic cancer who have inherited mutations in […]
Some women with endometrial cancer may be able to receive less intensive treatment than is commonly given to patients without increasing the risk of the disease recurring within 5 years, according to the results […]
Cancer immunotherapy relies on getting T cells—the immune system’s primary killers of infected and diseased cells—to attack and kill tumor cells. But there’s an important stumbling block for immunotherapy: T cells’ ability to kill […]
Radiation therapy, a widely used treatment for brain metastases, can impair important brain functions like memory, processing speed, and attention span, often greatly affecting patients’ quality of life. Initial results from a large […]
Results from a new study may explain how astrocytes, a type of brain cell, can drive the spread of cancer to the brain. In the study, researchers showed that astrocytes can activate a […]